Deep Genomics
Deep Genomics combines artificial intelligence (AI) and RNA biology to program and prioritize transformational AI-enabled therapies for almost any gene in any genetic condition. The proprietary platform, called the AI Workbench, allows Deep Genomics to decode vast amounts of data on RNA biology, identify novel targets for genetic diseases, and produce therapeutic programs with a high success rate. Almost everyone will suffer from a genetic condition at some point in their life, and Deep Genomics aims to be there for them with a genetically precise therapy. Deep Genomics is located in Toronto, Ontario, and Cambridge, Massachusetts.
About Deep Genomics
Founded
2014Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$237MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
TorontoState
OntarioCountry
CanadaDeep Genomics
Find your buyer within Deep Genomics